Blog, Quality | August 4, 2020 |

Partnership accelerates discovery with image analysis and management integration

Despite the ever-expanding array of technological advancements, image-based research remains limited by the lack of integration between analysis applications and the image management systems central to organizing study data. The disconnect creates bottlenecks in running analysis applications at scale and limits the impact that powerful image analysis results can have as a component of high-throughput research.

Streamline digital precision pathology

That is why Visiopharm, the leader in precision pathology software, and Proscia, a leader in digital pathology image and workflow management, have joined forces to integrate image analysis and image management in a single unified solution. The solution enables life sciences organizations to streamline workflows and accelerate breakthroughs by better leveraging computational image data in research and discovery.

Integrating two powerful platforms

Announced in March, the integrated solution connects Visiopharm’s AI-image analysis suite with Proscia’s Concentriq® for Research image management solution. The integration allows scientists and pathologists to automatically stream images from Concentriq into the VIS suite for analysis and then push results back into Concentriq, where they can be visualized and incorporated into ongoing studies by collaboration partners around the globe.


With a library of over 100 image analysis applications ready to apply to tissue data plus the possibility to modify and create new applications, the Visiopharm software suite enables virtually endless possibilities when it comes to discovering cells, tissues, regions, or any other important piece of data within whole slide images.

Concentriq for Research is an open digital pathology image management system used by leading life sciences organizations to generate big data insights from tissue-based research. It serves as a central hub for managing single or multi-site studies, connecting image analysis applications, information systems, and scanners to streamline image-based workflows. Through the integration, Visiopharm and Proscia are creating a connected digital ecosystem that eliminates data silos and facilitates the introduction of analysis results into routine research. As a result, users can make faster, more informed decisions by harnessing the power of integrated image analysis at scale.

Watch our joint webinar to learn more

Learn more about the new possibilities to collaborate on digital pathology projects and how Visiopharm’s and Proscia’s integrated solution work in detail? Watch the joint webinar Integrated Image Analysis At Scale: Visiopharm and Proscia’s Unified Solution.

Share this article

Share the link on Twitter Share the link on LinkedIn

About Visiopharm A/S

Visiopharm® is a world leader in AI-driven precision pathology software.

Visiopharm’s pioneering image analysis tools support thousands of scientists, pathologists, and image analysis experts in academic institutions, biopharmaceutical industry, and diagnostic centers. Our AI-based image analysis and tissue mining tools support research and drug development research worldwide, while CE-IVD APPs support primary diagnostics. With the most advanced and sophisticated artificial intelligence and deep learning, Visiopharm delivers tissue data mining tools, precision results, and workflows.

Visiopharm was founded in 2001 and is privately owned. The company operates internationally with over 900 licenses and countless users in more than 40 countries. The company headquarters are in Denmark’s Medicon Valley, with offices in Sweden, England, Germany, and the United States.

Learn everything about digital pathology
Knowledge Library

Latest news

Your message has been successfully sent!